Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
Hypertens Pregnancy. 2023 Dec;42(1):2268991. doi: 10.1080/10641955.2023.2268991. Epub 2023 Oct 17.NO ABSTRACTPMID:37847187 | DOI:10.1080/10641955.2023.2268991 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Women with preeclampsia may have reduced risk of breast cancer: a meta-analysis of cohort studies with 7.8 million participants
Hypertens Pregnancy. 2023 Dec;42(1):2265482. doi: 10.1080/10641955.2023.2265482. Epub 2023 Oct 17.ABSTRACTThis review pooled data from the literature to examine the association between preeclampsia (PE) and subsequent risk of breast cancer in women. Cohort studies published in the databases of PubMed, Embase, Scopus, and Web of Science up to 18 July 2023 were searched. Adjusted data were pooled to obtain the risk ratio (RR). Eleven studies with 15 cohorts and a cumulative sample size of 7,838,693 women were included. Meta-analysis of all studies demonstrated a reduced risk of breast cancer in women with PE as compared to t...
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Authors: Min Yao Lijie Chen Puchao Peng Zhiwei Zhong Source Type: research
Statement of Retraction: Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: A 3-year observational study
Hypertens Pregnancy. 2023 Dec;42(1):2268984. doi: 10.1080/10641955.2023.2268984. Epub 2023 Oct 17.NO ABSTRACTPMID:37847182 | DOI:10.1080/10641955.2023.2268984 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Statement of Retraction: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk
Hypertens Pregnancy. 2023 Dec;42(1):2268988. doi: 10.1080/10641955.2023.2268988. Epub 2023 Oct 17.NO ABSTRACTPMID:37847184 | DOI:10.1080/10641955.2023.2268988 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
Hypertens Pregnancy. 2023 Dec;42(1):2268991. doi: 10.1080/10641955.2023.2268991. Epub 2023 Oct 17.NO ABSTRACTPMID:37847187 | DOI:10.1080/10641955.2023.2268991 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Women with preeclampsia may have reduced risk of breast cancer: a meta-analysis of cohort studies with 7.8 million participants
Hypertens Pregnancy. 2023 Dec;42(1):2265482. doi: 10.1080/10641955.2023.2265482. Epub 2023 Oct 17.ABSTRACTThis review pooled data from the literature to examine the association between preeclampsia (PE) and subsequent risk of breast cancer in women. Cohort studies published in the databases of PubMed, Embase, Scopus, and Web of Science up to 18 July 2023 were searched. Adjusted data were pooled to obtain the risk ratio (RR). Eleven studies with 15 cohorts and a cumulative sample size of 7,838,693 women were included. Meta-analysis of all studies demonstrated a reduced risk of breast cancer in women with PE as compared to t...
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Authors: Min Yao Lijie Chen Puchao Peng Zhiwei Zhong Source Type: research
Statement of Retraction: Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: A 3-year observational study
Hypertens Pregnancy. 2023 Dec;42(1):2268984. doi: 10.1080/10641955.2023.2268984. Epub 2023 Oct 17.NO ABSTRACTPMID:37847182 | DOI:10.1080/10641955.2023.2268984 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Statement of Retraction: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk
Hypertens Pregnancy. 2023 Dec;42(1):2268988. doi: 10.1080/10641955.2023.2268988. Epub 2023 Oct 17.NO ABSTRACTPMID:37847184 | DOI:10.1080/10641955.2023.2268988 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
Hypertens Pregnancy. 2023 Dec;42(1):2268991. doi: 10.1080/10641955.2023.2268991. Epub 2023 Oct 17.NO ABSTRACTPMID:37847187 | DOI:10.1080/10641955.2023.2268991 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Women with preeclampsia may have reduced risk of breast cancer: a meta-analysis of cohort studies with 7.8 million participants
Hypertens Pregnancy. 2023 Dec;42(1):2265482. doi: 10.1080/10641955.2023.2265482. Epub 2023 Oct 17.ABSTRACTThis review pooled data from the literature to examine the association between preeclampsia (PE) and subsequent risk of breast cancer in women. Cohort studies published in the databases of PubMed, Embase, Scopus, and Web of Science up to 18 July 2023 were searched. Adjusted data were pooled to obtain the risk ratio (RR). Eleven studies with 15 cohorts and a cumulative sample size of 7,838,693 women were included. Meta-analysis of all studies demonstrated a reduced risk of breast cancer in women with PE as compared to t...
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Authors: Min Yao Lijie Chen Puchao Peng Zhiwei Zhong Source Type: research
Statement of Retraction: Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: A 3-year observational study
Hypertens Pregnancy. 2023 Dec;42(1):2268984. doi: 10.1080/10641955.2023.2268984. Epub 2023 Oct 17.NO ABSTRACTPMID:37847182 | DOI:10.1080/10641955.2023.2268984 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Statement of Retraction: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk
Hypertens Pregnancy. 2023 Dec;42(1):2268988. doi: 10.1080/10641955.2023.2268988. Epub 2023 Oct 17.NO ABSTRACTPMID:37847184 | DOI:10.1080/10641955.2023.2268988 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial
Hypertens Pregnancy. 2023 Dec;42(1):2268991. doi: 10.1080/10641955.2023.2268991. Epub 2023 Oct 17.NO ABSTRACTPMID:37847187 | DOI:10.1080/10641955.2023.2268991 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
Women with preeclampsia may have reduced risk of breast cancer: a meta-analysis of cohort studies with 7.8 million participants
Hypertens Pregnancy. 2023 Dec;42(1):2265482. doi: 10.1080/10641955.2023.2265482. Epub 2023 Oct 17.ABSTRACTThis review pooled data from the literature to examine the association between preeclampsia (PE) and subsequent risk of breast cancer in women. Cohort studies published in the databases of PubMed, Embase, Scopus, and Web of Science up to 18 July 2023 were searched. Adjusted data were pooled to obtain the risk ratio (RR). Eleven studies with 15 cohorts and a cumulative sample size of 7,838,693 women were included. Meta-analysis of all studies demonstrated a reduced risk of breast cancer in women with PE as compared to t...
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Authors: Min Yao Lijie Chen Puchao Peng Zhiwei Zhong Source Type: research
Statement of Retraction: Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: A 3-year observational study
Hypertens Pregnancy. 2023 Dec;42(1):2268984. doi: 10.1080/10641955.2023.2268984. Epub 2023 Oct 17.NO ABSTRACTPMID:37847182 | DOI:10.1080/10641955.2023.2268984 (Source: Hypertension in Pregnancy)
Source: Hypertension in Pregnancy - October 17, 2023 Category: OBGYN Source Type: research
